Delonix Bioworks
About:
Delonix Bioworks is working on synthetic biology approaches to develop the next generation medical solutions for infectious diseases.
Website: http://www.delonixbio.com
Top Investors: ZhenFund, Boehringer Ingelheim Venture Fund, IDG Capital
Description:
Delonix Bioworks Ltd. is a synthetic Biology inspired Medicines, they esign and engineer microbial strains rationally to manufacture or as medicines for infectious diseases, cancer and beyond.
Total Funding Amount:
$14M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2020-01-01
Founders:
Qiubin Lin
Number of Employees:
51-100
Last Funding Date:
2021-03-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai